Biowaiver as a Bioequivalence Study Option

SCIENTIFIC RELEVANCE. Biowaiver is a procedure for establishing the bioequivalence of generic and reference products without in vivo studies. Regulatory requirements for this procedure, as described in a variety of documents, differ in certain features and aspects. These differences need to be analy...

ver descrição completa

Detalhes bibliográficos
Principais autores: E. A. Volkova, Yu. V. Medvedev, E. N. Fisher, I. E. Shohin
Formato: Artigo
Idioma:Russian
Publicado em: Federal State Budgetary Institution ‘Scientific Centre for Expert Evaluation of Medicinal Products’ of the Ministry of Health of the Russian Federation (FSBI ‘SCEEMP’) 2024-02-01
coleção:Регуляторные исследования и экспертиза лекарственных средств
Assuntos:
Acesso em linha:https://www.vedomostincesmp.ru/jour/article/view/569